108 related articles for article (PubMed ID: 31743250)
1. Evaluation of Quality of Life in Patients With Chronic Inflammatory Demyelinating Polyneuropathy in Iran.
Okhovat AA; Gholamalizadeh S; Nafissi S; Fatehi F
J Clin Neuromuscul Dis; 2019 Dec; 21(2):77-83. PubMed ID: 31743250
[TBL] [Abstract][Full Text] [Related]
2. Quality of life predictors in patients with chronic inflammatory demyelinating polyradiculoneuropathy.
Bozovic I; Kacar A; Peric S; Nikolic A; Bjelica B; Cobeljic M; Petrovic M; Stojanov A; Djuric V; Stojanovic M; Djordjevic G; Martic V; Dominovic A; Vukojevic Z; Basta I
J Neurol; 2017 Dec; 264(12):2481-2486. PubMed ID: 29086018
[TBL] [Abstract][Full Text] [Related]
3. Quality of life in chronic inflammatory demyelinating polyneuropathy patients treated with subcutaneous immunoglobulin.
Ryltoft AK; Al-Zuhairy A; Sindrup SH; Andersen H; Markvardsen LK
Acta Neurol Scand; 2020 Dec; 142(6):637-640. PubMed ID: 33404110
[TBL] [Abstract][Full Text] [Related]
4. Quality of life in inflammatory neuropathies: the IN-QoL.
Draak THP; Faber CG; Merkies ISJ;
J Neurol Neurosurg Psychiatry; 2018 Mar; 89(3):256-262. PubMed ID: 28986470
[TBL] [Abstract][Full Text] [Related]
5. Understanding the consequences of chronic inflammatory demyelinating polyradiculoneuropathy from impairments to activity and participation restrictions and reduced quality of life: the ICE study.
Merkies IS; Hughes RA; Donofrio P; Bril V; Dalakas MC; Hanna K; Hartung HP; Latov N; van Doorn PA; Deng C;
J Peripher Nerv Syst; 2010 Sep; 15(3):208-15. PubMed ID: 21040143
[TBL] [Abstract][Full Text] [Related]
6. Clinical correlates of fatigue in chronic inflammatory demyelinating polyneuropathy.
Lawley A; Abbas A; Seri S; Rajabally YA
Muscle Nerve; 2020 Aug; 62(2):226-232. PubMed ID: 32388856
[TBL] [Abstract][Full Text] [Related]
7. Chronic inflammatory demyelinating polyneuropathy: quality of life, sociodemographic profile and physical complaints.
Santos PL; Almeida-Ribeiro GA; Silva DM; Marques Junior W; Barreira AA
Arq Neuropsiquiatr; 2014 Mar; 72(3):179-83. PubMed ID: 24676433
[TBL] [Abstract][Full Text] [Related]
8. Neuromuscular disease-specific questionnaire to assess quality of life in patients with chronic inflammatory demyelinating polyradiculoneuropathy.
Kacar A; Bjelica B; Bozovic I; Peric S; Nikolic A; Cobeljic M; Petrovic M; Stojanov A; Djordjevic G; Vukojevic Z; Dominovic-Kovacevic A; Stojanovic M; Stevic Z; Rakocevic-Stojanovic V; Lavrnic D; Basta I
J Peripher Nerv Syst; 2018 Mar; 23(1):11-16. PubMed ID: 29360221
[TBL] [Abstract][Full Text] [Related]
9. Validation of the Serbian version of inflammatory Rasch-built overall disability scale in patients with chronic inflammatory demyelinating polyradiculoneuropathy.
Peric S; Bozovic I; Pruppers MHJ; Bjelica B; Stevic Z; Faber CG; Merkies ISJ; Basta I
J Peripher Nerv Syst; 2019 Sep; 24(3):260-267. PubMed ID: 31397933
[TBL] [Abstract][Full Text] [Related]
10. Muscle performance relates to physical function and quality of life in long-term chronic inflammatory demyelinating polyradiculoneuropathy.
Harbo T; Andersen H; Overgaard K; Jakobsen J
J Peripher Nerv Syst; 2008 Sep; 13(3):208-17. PubMed ID: 18844787
[TBL] [Abstract][Full Text] [Related]
11. Subcutaneous immunoglobulin preserves muscle strength in chronic inflammatory demyelinating polyneuropathy.
Markvardsen LH; Harbo T; Sindrup SH; Christiansen I; Andersen H; Jakobsen J;
Eur J Neurol; 2014 Dec; 21(12):1465-70. PubMed ID: 25041191
[TBL] [Abstract][Full Text] [Related]
12. Prospective analysis of disability and quality of life in patients with chronic inflammatory demyelinating polyradiculoneuropathy.
Bozovic I; Peric M; Arsic Azanjac A; Palibrk A; Bulatovic I; Aleksic D; Peric S; Basta I
Qual Life Res; 2021 Sep; 30(9):2573-2579. PubMed ID: 33830457
[TBL] [Abstract][Full Text] [Related]
13. Chronic Acquired Polyneuropathy Patient Reported Index (CAPPRI) in chronic inflammatory demyelinating polyradiculoneuropathy.
Bjelica B; Peric S; Gwathmey K; Sadjadi R; Bozovic I; Burns TM; Basta I
J Peripher Nerv Syst; 2019 Sep; 24(3):247-252. PubMed ID: 31209940
[TBL] [Abstract][Full Text] [Related]
14. Subcutaneous immunoglobulin as first-line therapy in treatment-naive patients with chronic inflammatory demyelinating polyneuropathy: randomized controlled trial study.
Markvardsen LH; Sindrup SH; Christiansen I; Olsen NK; Jakobsen J; Andersen H;
Eur J Neurol; 2017 Feb; 24(2):412-418. PubMed ID: 28000311
[TBL] [Abstract][Full Text] [Related]
15. Costs of illness in chronic inflammatory demyelinating polyneuropathy in Germany.
Mengel D; Fraune L; Sommer N; Stettner M; Reese JP; Dams J; Glynn RJ; Balzer-Geldsetzer M; Dodel R; Tackenberg B
Muscle Nerve; 2018 Nov; 58(5):681-687. PubMed ID: 30073683
[TBL] [Abstract][Full Text] [Related]
16. Impact of environmental factors and physical activity on disability and quality of life in CIDP.
Doneddu PE; Bianchi E; Cocito D; Manganelli F; Fazio R; Filosto M; Beghi E; Mazzeo A; Cosentino G; Cortese A; Jann S; Clerici AM; Antonini G; Siciliano G; Marfia GA; Briani C; Lauria G; Rosso T; Cavaletti G; Carpo M; Benedetti L; Schenone A; Liberatore G; Peci E; Spina E; Tronci S; Cotti Piccinelli S; Toscano A; Gentile L; Piccolo L; Leonardi L; Mataluni G; Ruiz M; Sabatelli M; Santoro L; Nobile-Orazio E;
J Neurol; 2020 Sep; 267(9):2683-2691. PubMed ID: 32430573
[TBL] [Abstract][Full Text] [Related]
17. Long-term neurophysiological and clinical response in patients with chronic inflammatory demyelinating polyradiculoneuropathy treated with subcutaneous immunoglobulin.
Cirillo G; Todisco V; Tedeschi G
Clin Neurophysiol; 2018 May; 129(5):967-973. PubMed ID: 29554579
[TBL] [Abstract][Full Text] [Related]
18. Correlation of clinical and neurophysiological findings with health-related quality of life in patients with diabetic polyneuropathy.
Vukojević Z; Pekmezović T; Nikolić A; Perić S; Basta I; Marjanović I; Lavrnić D
Vojnosanit Pregl; 2014 Sep; 71(9):833-8. PubMed ID: 25282781
[TBL] [Abstract][Full Text] [Related]
19. Increased muscle echointensity correlates with clinical disability and muscle strength in chronic inflammatory demyelinating polyneuropathy.
Fisse AL; Fiegert S; Stoykova Z; Brünger J; Athanasopoulos D; Grüter T; Motte J; Gold R; Pitarokoili K
Eur J Neurol; 2021 May; 28(5):1698-1705. PubMed ID: 33404183
[TBL] [Abstract][Full Text] [Related]
20. Fatigue, Pain, Anxiety and Depression in Guillain-Barré Syndrome and Chronic Inflammatory Demyelinating Polyradiculoneuropathy.
Merkies IS; Kieseier BC
Eur Neurol; 2016; 75(3-4):199-206. PubMed ID: 27077919
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
